Literature DB >> 11238650

Bactericidal properties of group IIA and group V phospholipases A2.

J O Grönroos1, V J Laine, M J Janssen, M R Egmond, T J Nevalainen.   

Abstract

Group V phospholipase A(2) (PLA(2)) is a recently characterized 14-kDa secretory PLA(2) of mammalian heart and macrophage-derived cells. Group IIA PLA(2), which is structurally close to group V PLA(2), has been shown to kill Gram-positive bacteria in vitro and to prevent symptoms of Gram-positive infection in vivo. We studied the antibacterial properties of fully active recombinant rat group IIA and V PLA(2)s. Both group IIA and V PLA(2)s were highly bactericidal against Gram-positive bacteria, including methicillin-resistant staphylococci and vancomycin-resistant enterococci. Only high concentrations of group IIA PLA(2) showed some bactericidal effect against the Gram-negative bacterium Escherichia coli. Our results confirm that group IIA PLA(2) is a potent antibacterial enzyme against Gram-positive bacteria. Moreover, we show here that group V PLA(2) is a novel antibacterial mammalian protein, but is less potent than group IIA PLA(2). Both enzymes may be considered as future therapeutic agents against bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238650     DOI: 10.4049/jimmunol.166.6.4029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells.

Authors:  Michiko Mitsuishi; Seiko Masuda; Ichiro Kudo; Makoto Murakami
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.

Authors:  Jae-Ouk Kim; Bimal K Chakrabarti; Anuradha Guha-Niyogi; Mark K Louder; John R Mascola; Lakshmanan Ganesh; Gary J Nabel
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

5.  Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides.

Authors:  Hongxia Zhao; Paavo K J Kinnunen
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

6.  Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties.

Authors:  Timothy J Cunningham; Lihua Yao; Angel Lucena
Journal:  J Inflamm (Lond)       Date:  2008-10-22       Impact factor: 4.981

7.  Immunohistochemical study on the distribution of β-defensin 1 and β-defensin 2 throughout the respiratory tract of healthy rats.

Authors:  Natsumi Masuda; Youhei Mantani; Hideto Yuasa; Chiaki Yoshitomi; Masaya Arai; Miho Nishida; Wang-Mei Qi; Junichi Kawano; Toshifumi Yokoyama; Nobuhiko Hoshi; Hiroshi Kitagawa
Journal:  J Vet Med Sci       Date:  2018-01-01       Impact factor: 1.267

8.  Comparative Study of Antimicrobial Properties of Bee Venom Extracts and Melittins of Honey Bees.

Authors:  Jakkrawut Maitip; Wannapha Mookhploy; Supharerk Khorndork; Panuwan Chantawannakul
Journal:  Antibiotics (Basel)       Date:  2021-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.